Who owns Valeant Pharmaceuticals Int?

Key details on Valeant Pharmaceuticals Int (Ticker: VRX)

Who owns Valeant Pharmaceuticals Int?

Is VRX a good stock to own? Find out who bought Valeant Pharmaceuticals Int, who sold Valeant Pharmaceuticals Int (VRX) stock, and who holds a large position in Valeant Pharmaceuticals Int.

Fund Name Number of Shares Share Valuation As Of
Ruane, Cunniff & Goldfarb 34.22M $4.51B March 31, 2014
FMR 22.89M $3.01B March 31, 2014
ValueAct Holdings 18.92M $2.49B March 31, 2014
T. Rowe Price Associates 14.06M $1.85B March 31, 2014
VIKING GLOBAL INVESTORS 9.30M $1.23B March 31, 2014
Lone Pine Capital 8.82M $1.16B March 31, 2014
Barclays 8.75M $1.15B March 31, 2014
BANK OF MONTREAL /CAN/ 8.01M $1.06B March 31, 2014
Toronto-Dominion Bank 7.92M $1.04B March 31, 2014
Blue Ridge Capital Holdings 7.52M $279.13M Sept. 30, 2011
JPMORGAN CHASE & CO 7.25M $955.92M March 31, 2014
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 5.86M $772.49M March 31, 2014
Brave Warrior Advisors 5.59M $737.27M March 31, 2014
Blue Ridge Capital 5.45M $254.46M Dec. 31, 2011
Loomis, Sayles and 4.69M $550.74M Dec. 31, 2013
Janus Capital Management 4.54M $391.19M June 30, 2013
CIBC World Markets 4.42M $582.34M March 31, 2014
Brave Warrior Capital 4.41M $236.94M March 31, 2012
Brahman Capital 4.36M $241.01M Sept. 30, 2012
MORGAN STANLEY 4.36M $574.15M March 31, 2014
Connor, Clark & Lunn Investment Management 4.25M $529.78M Dec. 31, 2013
Caisse de depot et placement du Quebec 4.13M $543.55M March 31, 2014
Orbis Holdings 4.01M $418.70M Sept. 30, 2013
Greystone Managed Investment 4.01M $179.42M June 30, 2012
Name Goodman & Company, Investment Counsel 3.95M $230.07M Dec. 31, 2012
GOLDMAN SACHS 3.95M $218.16M Sept. 30, 2012
Royal Bank of Canada 3.94M $519.80M March 31, 2014
Iridian Asset Management 3.88M $214.41M Sept. 30, 2012
Connor, Clark & Lunn Investment Management 3.85M $559.60M March 31, 2014

Who sold Valeant Pharmaceuticals Int?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Sept. 30, 2012 4.86M $255.76M
HARRIS FINANCIAL Sept. 30, 2011 5.69M $211.13M
Nicholas Investments Partners June 30, 2011 4.40M $4.36M
Commerzbank Aktiengesellschaft Dec. 31, 2010 5.42M $153.32M
Osterweis Capital Management Dec. 31, 2010 4.82M $136.26M